GT Biopharma Inc

NASDAQ: GTBP    
Share price (4/26/24): $3.35    
Market cap (4/26/24): $4.618 million
Search in Documents
Key Exhibits
External Links

Indentures Filter

EX-4.3
from 10-K 3 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934, as Amended
12/34/56
EX-4.3
from 8-K 17 pages Placement Agent Common Stock Purchase Warrant GT Biopharma, Inc
12/34/56
EX-4.2
from 8-K 16 pages Pre-Funded Common Stock Purchase Warrant GT Biopharma, Inc
12/34/56
EX-4.1
from 8-K 17 pages Common Stock Purchase Warrant GT Biopharma, Inc
12/34/56
EX-4.2
from 10-K 5 pages Certificate of Designation of Preferences, Rights and Limitations of Series K Preferred Stock of GT Biopharma, Inc
12/34/56
EX-4.3
from S-1/A 14 pages [Form of Pre-Funded Warrant] GT Biopharma, Inc. Pre-Funded Warrant to Purchase Common Stock
12/34/56
EX-4.2
from S-1/A 16 pages [Form of Warrant] GT Biopharma, Inc. Warrant to Purchase Common Stock
12/34/56
EX-4.1
from 8-K 16 pages Convertible Note Due: , 2021
12/34/56
EX-4.1
from 8-K 20 pages Convertible Note Due: , 2021
12/34/56
EX-4.1
from 8-K 21 pages Convertible Note Due
12/34/56
EX-4.1
from 8-K 20 pages Convertible Note Due
12/34/56
EX-4.1
from 8-K 21 pages Convertible Note Due November ___, 2019
12/34/56
EX-4.1
from 8-K 21 pages Secured Convertible Note Due August 2, 2019
12/34/56
EX-4.1
from 8-K 23 pages 10% Senior Convertible Debenture Due September 24, 2019
12/34/56
EX-4.1
from 8-K 25 pages 10% Senior Convertible Debenture Due , 2019
12/34/56
EX-4.1
from 8-K 17 pages 10% Senior Convertible Debenture Due August 2, 2019
12/34/56
EX-4.1
from 10-Q 6 pages Certificate of Designation of Preferences, Rights and Limitaitons of Series J Preferred Stock of GT Biopharma, Inc
12/34/56
EX-4.4
from S-1/A 5 pages Certificate of Designation of Preferences, Rights and Limitaitons of Series J Convertible Preferred Stock of Oxis International, Inc
12/34/56
EX-4.4
from S-1 ~5 pages Certificate of Designation of Preferences, Rights and Limitaitons of Series J Convertible Preferred Stock of Oxis International, Inc
12/34/56
EX-4.1
from S-8 4 pages Consulting Agreement
12/34/56